Skip to Content
  • Prev Rank
    3
  • Location
    Anaheim, Calif.
  • Industry
    Pharmaceuticals
  • Sector
    Health Care
  • F1000 Rank-
  • G500 Rank-
  • Current Streak
    3

A remarkable transformation from obscure to blockbuster wonder drug: In the early 1990s, anti-inflammatory Acthar Gel sold for $50 per vial. Questor bought rights to the low-key drug in 2001 and began marketing it widely as a wonder drug used to treat kids with severe seizures.

In 2007, Acthar’s price increased from $1,650 to a whopping $23,000 for a 5-milliliter vial. The company explained that the astronomical price hike was needed to keep the drug available on the small, rare diseases market.

Today, a vial costs $28,000 and Questor has seen its annual revenues surge 97% in the past three years. In April, Questor was bought by Dublin-based pharma Mallinckrodt for $5.6 billion. —Vivian Giang

Fortune Data StoreLooking for leads, investment insights, or competitive intelligence?Get Premium Access

Company Information

Location
Anaheim, Calif.
Industry
Pharmaceuticals
Sector
Health Care
Current Streak
3

Revenue, Net Income

Revenue Past Four Quarters
891
Net Income Past Four Quarters327.9

Growth Rates & Ranks

EPS Growth Rank13
EPS 3 yr Annual Growth Rate Pct115
Revenue Growth Rank3
Rev 3 yr Annual Growth Rate97
Total Return 3 yr Annual Rate59
Total Return Rank
15
Beat S&P 3 yr Annual Growth Rate?
yes
P/E current fiscal year profits (est.)
12.7